Workflow
Save Foods(SVFD) - 2024 Q3 - Quarterly Report
SVFDSave Foods(SVFD)2024-11-14 21:15

Financial Performance - Revenues from product sales for the nine months ended September 30, 2024, were 69,481,down56.069,481, down 56.0% from 157,618 for the same period in 2023[14]. - The company reported a net loss of 3,936,207fortheninemonthsendedSeptember30,2024,comparedtoanetlossof3,936,207 for the nine months ended September 30, 2024, compared to a net loss of 5,472,512 for the same period in 2023, indicating an improvement of approximately 28.1%[14]. - Comprehensive loss for the period was (2,263,210)forSeptember30,2024,comparedto(2,263,210) for September 30, 2024, compared to (2,365,596) for September 30, 2023, indicating a decrease in losses[33]. - The operating loss for the three months ended September 30, 2024, was 469,759,comparedtoanoperatinglossof469,759, compared to an operating loss of 1,978,992 for the same period in 2023[117]. - The Company reported a net loss of 3,036,028forthethreemonthsendedSeptember30,2023[119].AssetsandLiabilitiesAsofSeptember30,2024,totalcurrentassetsdecreasedto3,036,028 for the three months ended September 30, 2023[119]. Assets and Liabilities - As of September 30, 2024, total current assets decreased to 3,371,137 from 5,465,621asofDecember31,2023,representingadeclineofapproximately38.35,465,621 as of December 31, 2023, representing a decline of approximately 38.3%[10]. - Total liabilities decreased to 518,764 as of September 30, 2024, from 785,653asofDecember31,2023,areductionofapproximately33.9785,653 as of December 31, 2023, a reduction of approximately 33.9%[12]. - The company’s cash and cash equivalents decreased to 2,749,851 as of September 30, 2024, down from 4,447,003asofDecember31,2023,adeclineofapproximately38.24,447,003 as of December 31, 2023, a decline of approximately 38.2%[10]. - The balance at September 30, 2023, was 1,445,558 in total equity, compared to 688,272atDecember31,2022,showinganincreaseinequity[28].AsofSeptember30,2024,thecompanyslonglivedassetstotaled688,272 at December 31, 2022, showing an increase in equity[28]. - As of September 30, 2024, the company's long-lived assets totaled 68,640,000, a decrease from 123,149,000asofDecember31,2023,representingadeclineofapproximately44.5123,149,000 as of December 31, 2023, representing a decline of approximately 44.5%[123]. Cash Flow - Net cash used in operating activities was (2,927,148) for the nine months ended September 30, 2024, compared to (2,258,869)forthesameperiodin2023,reflectinganincreaseincashoutflow[35].Thecompanyreportedadecreaseincashflowsfrominvestingactivitiesto(2,258,869) for the same period in 2023, reflecting an increase in cash outflow[35]. - The company reported a decrease in cash flows from investing activities to (1,373,044) for the nine months ended September 30, 2024, compared to (1,519,559)forthesameperiodin2023[35].Cash,cashequivalents,andrestrictedcashattheendoftheperiodwere(1,519,559) for the same period in 2023[35]. - Cash, cash equivalents, and restricted cash at the end of the period were 2,772,981 for September 30, 2024, down from 4,478,174atthebeginningoftheyear[34].ShareholderInformationThenumberofsharesoutstandingincreasedto9,580,515asofSeptember30,2024,from2,955,490asofDecember31,2023,reflectingasignificantincreaseduetoareversestocksplit[12].ThecompanyhasrestatedallsharesandpershareinformationinitsfinancialstatementstoreflectaoneforsevenreversestockspliteffectiveOctober5,2023[43][42].TheCompanyissued1,690,000sharesofcommonstocktoexecutiveofficersandconsultants,valuedat4,478,174 at the beginning of the year[34]. Shareholder Information - The number of shares outstanding increased to 9,580,515 as of September 30, 2024, from 2,955,490 as of December 31, 2023, reflecting a significant increase due to a reverse stock split[12]. - The company has restated all shares and per share information in its financial statements to reflect a one-for-seven reverse stock split effective October 5, 2023[43][42]. - The Company issued 1,690,000 shares of common stock to executive officers and consultants, valued at 463,905, recorded as share-based compensation expenses[108]. - The Company issued 1,777,722 shares of common stock for 577,002inOctober2024,bringingthetotalsharesissuedundertheSEPAIIagreementto6,666,667,whichisthemaximumallowed[124].StrategicDevelopmentsThecompanychangeditsnamefrom"SaveFoods,Inc."to"N2OFF,Inc."anditstradingsymbolfrom"SVFD"to"NITO"onMarch19,2024[8].ThecompanyhasformedanewIsraelisubsidiary,NTWOOFFLtd.,focusingonnitrousoxide,aspartofitsmarketexpansionstrategy[40].Thecompanyisactivelypursuingpartnerships,asevidencedbythesecuritiesexchangeagreementwithPlantifyFoods,Inc.,focusingoncleanlabelplantbasedproducts[39].TheCompanyplanstoacquireMitoCareXBioLtd.forcashconsiderationof577,002 in October 2024, bringing the total shares issued under the SEPA II agreement to 6,666,667, which is the maximum allowed[124]. Strategic Developments - The company changed its name from "Save Foods, Inc." to "N2OFF, Inc." and its trading symbol from "SVFD" to "NITO" on March 19, 2024[8]. - The company has formed a new Israeli subsidiary, NTWO OFF Ltd., focusing on nitrous oxide, as part of its market expansion strategy[40]. - The company is actively pursuing partnerships, as evidenced by the securities exchange agreement with Plantify Foods, Inc., focusing on clean-label plant-based products[39]. - The Company plans to acquire MitoCareX Bio Ltd. for cash consideration of 700,000 and additional shares based on performance milestones[92]. - The acquisition of MitoCareX is contingent upon entering into a definitive agreement and meeting customary closing conditions[95]. Risks and Challenges - The company faces significant risks including ongoing geopolitical conflicts that may adversely affect operations and revenue generation[6]. - The ongoing conflict has led to a decrease in Israel's economic activity, which may adversely affect the company's business operations[52]. - The company has experienced delays in pilots and packaging activities due to the ongoing war, affecting its ability to pursue new collaborations[53]. - Operations at Plantify have ceased due to ongoing hostilities, with all employees placed on unpaid leave[54]. - Management believes existing cash will be sufficient to fund operations until the end of Q3 2025, raising substantial doubt about the company's ability to continue as a going concern[46]. Financing Activities - The company is seeking additional financing through equity securities or strategic partnerships to support its operations[47]. - The Company entered into a Standby Equity Purchase Agreement (SEPA II) with YA II PN, Ltd., allowing the purchase of up to 20millionincommonstockover36months,withsharespricedat9420 million in common stock over 36 months, with shares priced at 94% of the lowest VWAP for three consecutive trading days[97]. - As of September 30, 2024, the Company issued 4,888,945 shares under SEPA II, valued at 2,223,242, with gross consideration of 2,557,743[101].TheCompanyenteredintoaLoanAgreementwithSolterraRenewableEnergyLtd.for375,000(approximately2,557,743[101]. - The Company entered into a Loan Agreement with Solterra Renewable Energy Ltd. for €375,000 (approximately 406,156) at a 7% interest rate, maturing in five years[85]. - The Company committed €1,560,000 (approximately $1,716,000) to a Loan and Partnership Agreement for solar energy projects, with a 7% interest rate[87]. Legal and Compliance - There were no changes in internal control over financial reporting that materially affected the company's controls during the reporting period[187].